Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models

This publication has 26 references indexed in Scilit:

• T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
  Antiviral Research, 2009
• Activity of T-705 in a Hamster Model of Yellow Fever Virus Infection in Comparison with That of a Chemically Related Compound, T-1106
  Antimicrobial Agents and Chemotherapy, 2009
• Prophylaxis with cationic liposome–DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs
  Antiviral Research, 2008
• EFFICACY OF POST-EXPOSURE TREATMENT OF YELLOW FEVER WITH RIBAVIRIN IN A HAMSTER MODEL OF THE DISEASE
  The American Journal of Tropical Medicine and Hygiene, 2004
• INDUCTION OF SEVERE DISEASE IN HAMSTERS BY TWO SANDFLY FEVER GROUP VIRUSES, PUNTA TORO AND GABEK FOREST (PHLEBOVIRUS, BUNYAVIRIDAE), SIMILAR TO THAT CAUSED BY RIFT VALLEY FEVER VIRUS
  The American Journal of Tropical Medicine and Hygiene, 2003
• Hemorrhagic Fever Viruses as Biological Weapons
  JAMA, 2002
• In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
  Antimicrobial Agents and Chemotherapy, 2002
• Experimental Yellow Fever Virus Infection in the Golden Hamster(Mesocricetus auratus).II. Pathology
  The Journal of Infectious Diseases, 2001
• Experimental Yellow Fever Virus Infection in the Golden Hamster(Mesocricetus auratus).I. Virologic, Biochemical, and Immunologic Studies
  The Journal of Infectious Diseases, 2001
• Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator
  Antiviral Research, 1986